RIPPLEâ„¢ (Remote Induction of Pulsed Pressure Lateral to Energy) is a proprietary ultrasound-mediated delivery ...
Attorneys Terrence Allen, Megan Gess, and Andrew Hagopian have joined Dorsey & Whitney LLP as Partners in the Mergers & ...
Phase 1/2a Clinical Study 36 Month Results Featured at Clinical Trials at the Summit 2025Achieved First Milestone Under Worldwide Collaboration with Genentech Based on RG6501 (OpRegen Cell Therapy) ...
Clinically meaningful data establishes proof of concept for elismetrep as a promising therapeutic candidate for migraine and its progression into registrational studies anticipated to initiate ...
Reported positive top-line data from Phase 2a proof-of-concept (POC) trial of EVO301 in atopic dermatitis (AD)– EVO756 on track to report Phase 2b top-line data in chronic spontaneous urticaria (CSU) ...
IPF, a global Phase 2 trial evaluating PIPE-791 for the treatment of patients with idiopathic pulmonary fibrosis (IPF)- Topline data from the exploratory PIPE-791 Phase 1b trial in patients with ...
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced management participation in two upcoming investor conferences.Charlie Wagner, Chief Operating and Financial Officer, and Duncan ...
GAIA, the pioneer in evidence-based digital therapeutics and Daiichi Sankyo Europe, today announced an exclusive strategic ...
Modular Genetics, Inc. (Modular) a leading Industrial Biotechnology company, is pleased to announce that it has joined the New American Industrial Alliance (NAIA). Membership will accelerate execution ...
SAN TAN VALLEY, AZ / ACCESS Newswire / March 5, 2026 / Medical Care Technologies Inc. (OTC PINK:MDCE) today announced that the highly anticipated "Legends Art Auction", hosted by its subsidiary ...
New South San Francisco center showcases how cutting-edge cryo-electron microscopy is transforming and accelerating drug discoverySOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Thermo Fisher Scientific ...
Global Capnography Equipment Market OverviewThe global capnography equipment market is anticipated to grow at a steady pace with an estimated compound annual growth rate of around 5% over the next ...